ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...
第一著者: | R.T. Saygitov |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
"Paediatrician" Publishers LLC
2008-08-01
|
シリーズ: | Вопросы современной педиатрии |
オンライン・アクセス: | https://vsp.spr-journal.ru/jour/article/view/1441 |
類似資料
-
ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
著者:: R.T. Saygitov
出版事項: (2008-01-01) -
Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
著者:: Cardile S, 等
出版事項: (2012-02-01) -
Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
著者:: Yu. V. Yevsyutina
出版事項: (2018-08-01) -
Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
著者:: Gold Benjamin D, 等
出版事項: (2009-11-01) -
Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
著者:: Roy C Orlando, 等
出版事項: (2010-09-01)